201 related articles for article (PubMed ID: 30539353)
1. Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort.
Zeña-Huancas PA; Iparraguirre-López H; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Zevallos-Miranda F; Medina-Chinchon M; Pimentel-Quiroz VR; Elera-Fitzcarrald C; Sarmiento-Velasquez O; Cucho-Venegas JM; Alfaro-Lozano JL; Rodríguez-Bellido ZJ; Pastor-Asurza CA; Perich-Campos RA; Alarcón GS; Ugarte-Gil MF
Clin Rheumatol; 2019 Apr; 38(4):1139-1146. PubMed ID: 30539353
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome predicts new damage in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
Elera-Fitzcarrald C; Reatégui-Sokolova C; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Cucho-Venegas JM; Alfaro-Lozano JL; Rodriguez-Bellido Z; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
Lupus; 2022 Jan; 31(1):105-109. PubMed ID: 34989640
[TBL] [Abstract][Full Text] [Related]
3. Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients.
Ugarte-Gil MF; Sánchez-Zúñiga C; Gamboa-Cardenas RV; Aliaga-Zamudio M; Zevallos F; Mosqueira-Riveros A; Medina-Chinchón M; Tineo-Pozo G; Elera-Fitzcarrald C; Pimentel-Quiroz V; Sarmiento-Velasquez O; Reátegui-Sokolova C; Cucho-Venegas JM; Alfaro-Lozano J; Rodriguez-Bellido Z; Pastor-Asurza C; Alarcón GS; Perich-Campos R
Clin Exp Rheumatol; 2018; 36(6):1008-1013. PubMed ID: 29745892
[TBL] [Abstract][Full Text] [Related]
4. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus.
Ugarte-Gil MF; Dubey J; McGwin G; Reveille JD; Vilá LM; Alarcón GS
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):585-589. PubMed ID: 35255194
[TBL] [Abstract][Full Text] [Related]
5. The SLICC-FI Predicts Damage Accrual in SLE Patients. Data From the Almenara Lupus Cohort.
Elera-Fitzcarrald C; Gamboa-Cárdenas RV; Reatégui-Sokolova C; Pimentel-Quiroz V; Rodriguez-Bellido Z; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
Lupus; 2022 Nov; 31(13):1666-1670. PubMed ID: 36165429
[TBL] [Abstract][Full Text] [Related]
6. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ugarte-Gil MF; Hanly J; Urowitz M; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Clarke AE; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Pons-Estel BA; Alarcón GS
Ann Rheum Dis; 2022 Nov; 81(11):1541-1548. PubMed ID: 35944946
[TBL] [Abstract][Full Text] [Related]
7. Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Nieto R; Quintana R; Zavala-Flores E; Serrano R; Roberts K; Catoggio LJ; García MA; Berbotto GA; Saurit V; Bonfa E; Borba EF; Lavras Costallat LT; Da Silva NA; Sato EI; Tavares Brenol JC; Massardo L; Neira OJ; Vázquez G; Guibert Toledano M; Pascual-Ramos V; Sauza Del Pozo MJ; Barile-Fabris LA; Amigo MC; García De La Torre I; Acevedo-Vásquez EM; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Alarcón GS; Pons-Estel BA; Pons-Estel GJ
Lupus; 2024 Apr; 33(4):340-346. PubMed ID: 38334100
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.
Reátegui-Sokolova C; Ugarte-Gil MF; Gamboa-Cárdenas RV; Zevallos F; Cucho-Venegas JM; Alfaro-Lozano JL; Medina M; Rodriguez-Bellido Z; Pastor-Asurza CA; Alarcón GS; Perich-Campos RA
Clin Rheumatol; 2017 Apr; 36(4):845-852. PubMed ID: 28101832
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
Legge A; Kirkland S; Rockwood K; Andreou P; Bae SC; Gordon C; Romero-Diaz J; Sanchez-Guerrero J; Wallace DJ; Bernatsky S; Clarke AE; Merrill JT; Ginzler EM; Fortin PR; Gladman DD; Urowitz MB; Bruce IN; Isenberg DA; Rahman A; Alarcón GS; Petri M; Khamashta MA; Dooley MA; Ramsey-Goldman R; Manzi S; Zoma AA; Aranow C; Mackay M; Ruiz-Irastorza G; Lim SS; Inanc M; van Vollenhoven RF; Jonsen A; Nived O; Ramos-Casals M; Kamen DL; Kalunian KC; Jacobsen S; Peschken CA; Askanase A; Hanly JG
Arthritis Rheumatol; 2020 Apr; 72(4):658-666. PubMed ID: 31631584
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid is associated with damage in patients with systemic lupus erythematosus.
Elera-Fitzcarrald C; Reátegui-Sokolova C; Gamboa-Cardenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Cucho-Venegas JM; Alfaro-Lozano J; Rodriguez-Bellido Z; Pastor-Asurza CA; Perich-Campos RA; Alarcón GS; Ugarte-Gil MF
Lupus Sci Med; 2020; 7(1):e000366. PubMed ID: 32153795
[TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
Elera-Fitzcarrald C; Reátegui-Sokolova C; Gamboa-Cárdenas RV; Medina M; Zevallos F; Pimentel-Quiroz VR; Zeña-Huancas PA; Pastor-Asurza CA; Perich-Campos RA; Rodríguez-Bellido ZJ; Alarcón GS; Ugarte-Gil MF
Lupus; 2020 Oct; 29(12):1644-1649. PubMed ID: 32741305
[TBL] [Abstract][Full Text] [Related]
12. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.
Ugarte-Gil MF; Acevedo-Vásquez E; Alarcón GS; Pastor-Asurza CA; Alfaro-Lozano JL; Cucho-Venegas JM; Segami MI; Wojdyla D; Soriano ER; Drenkard C; Brenol JC; de Oliveira e Silva Montandon AC; Costallat LT; Massardo L; Molina-Restrepo JF; Guibert-Toledano M; Silveira LH; Amigo MC; Barile-Fabris LA; Chacón-Díaz R; Esteva-Spinetti MH; Pons-Estel GJ; McGwin G; Pons-Estel BA;
Ann Rheum Dis; 2015 Jun; 74(6):1019-23. PubMed ID: 24525909
[TBL] [Abstract][Full Text] [Related]
13. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
Ugarte-Gil MF; Gamboa-Cardenas RV; Reátegui-Sokolova C; Pimentel-Quiroz VR; Medina M; Elera-Fitzcarrald C; Zevallos F; Pastor-Asurza CA; Lofland J; Zazzetti F; Karyekar CS; Alarcón GS; Perich-Campos RA
Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35193948
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.
Pimentel-Quiroz VR; Ugarte-Gil MF; Harvey GB; Wojdyla D; Pons-Estel GJ; Quintana R; Esposto A; García MA; Catoggio LJ; Cardiel MH; Barile LA; Amigo MC; Sato EI; Bonfa E; Borba E; Lavras Costallat LT; Neira OJ; Massardo L; Guibert-Toledano M; Chacón-Díaz R; Alarcón GS; Pons-Estel BA
Lupus; 2019 Aug; 28(9):1101-1110. PubMed ID: 31291843
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Bruce IN; O'Keeffe AG; Farewell V; Hanly JG; Manzi S; Su L; Gladman DD; Bae SC; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Wallace DJ; Clarke AE; Bernatsky S; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Alarcón GS; Fessler BJ; Fortin PR; Petri M; Steinsson K; Dooley MA; Khamashta MA; Ramsey-Goldman R; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim S; Kamen DL; Peschken CA; Inanc M; Urowitz MB
Ann Rheum Dis; 2015 Sep; 74(9):1706-13. PubMed ID: 24834926
[TBL] [Abstract][Full Text] [Related]
16. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).
Ugarte-Gil MF; Wojdyla D; Pons-Estel GJ; Catoggio LJ; Drenkard C; Sarano J; Berbotto GA; Borba EF; Sato EI; Tavares Brenol JC; Uribe O; Ramirez Gómez LA; Guibert-Toledano M; Massardo L; Cardiel MH; Silveira LH; Chacón-Diaz R; Alarcón GS; Pons-Estel BA;
Ann Rheum Dis; 2017 Dec; 76(12):2071-2074. PubMed ID: 28939626
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study.
Apostolopoulos D; Kandane-Rathnayake R; Louthrenoo W; Luo SF; Wu YJ; Lateef A; Golder V; Sockalingam S; Navarra S; Zamora L; Hamijoyo L; Katsumata Y; Harigai M; Chan M; O'Neill S; Goldblatt F; Lau CS; Li ZG; Hoi A; Nikpour M; Morand E;
Lancet Rheumatol; 2020 Jan; 2(1):e24-e30. PubMed ID: 38258272
[TBL] [Abstract][Full Text] [Related]
18. Association of the Systemic Lupus International Collaborating Clinics Frailty Index and Damage Accrual in Longstanding Systemic Lupus Erythematosus.
Lima K; Legge A; Hanly JG; Lee J; Song J; Chung A; Ramsey-Goldman R
Arthritis Care Res (Hoboken); 2023 Mar; 75(3):578-584. PubMed ID: 34590445
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort.
Pimentel-Quiroz VR; Ugarte-Gil MF; Pons-Estel GJ; Soriano ER; Saurit V; Sato EI; Lavras Costallat LT; Molina JF; Iglesias-Gamarra A; Reyes-Llerena G; Neira OJ; Barile LA; Silveira LH; Segami MI; Chacón-Díaz R; Wojdyla D; Alarcón GS; Pons-Estel BA
Semin Arthritis Rheum; 2017 Oct; 47(2):199-203. PubMed ID: 28291583
[TBL] [Abstract][Full Text] [Related]
20. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
Chitpet P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P; Leosuthamas P; Pakchotanon R
Int J Rheum Dis; 2023 Dec; 26(12):2509-2516. PubMed ID: 37875327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
